Senti Biosciences
SNTI
SNTI
26 hedge funds and large institutions have $16.6M invested in Senti Biosciences in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
40% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 10
40% less capital invested
Capital invested by funds: $27.8M → $16.6M (-$11.3M)
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$727K | |
| 2 | +$134K | |
| 3 | +$98.7K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$55.1K |
| 5 |
BlackRock
New York
|
+$52.8K |
Top Sellers
| 1 | -$1.4M | |
| 2 | -$651K | |
| 3 | -$248K | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$228K |
| 5 |
Morgan Stanley
New York
|
-$139K |